Pfizer Inc (PFE) – Recent acquisitions and pipeline update may boost growth in the future

in , on June 27, 2019

Pfizer’s revenues increased by 1.6% to $13.1bn in Q1FY19, which reflects operational growth of 5% and the unfavorable impact of foreign exchange of 4%. GAAP EPS increased by 15% to $0.68 in Q1FY19.

Number of Pages – 56


Executive Summary

Financial Statements

–Income Statement and Forecast

–Balance Sheet

–Cash Flow

–Q1FY19 Results – Overview

–Q1FY19 – Segment Performance

–Q1FY19 – Product Developments

–FY19 Guidance


–GAAP to Non-GAAP Reconciliation

Historical Performance

–Key Ratios

–Profitability Ratios, Asset Turnover Ratio, Growth Ratio

–Per Share Items and Key Ratios

–Key Balance Sheet and Cash Flow Items

–P/E Band

Product Performance and Key Developments



–Key Developments

Valuation and Consensus Performance

–Relative Valuation

–Analyst Recommendations

Market Price Performance

CrispIdea Coverage

Release Information

  • Released

    June 27, 2019

  • Last Updated

    June 27, 2019